tiprankstipranks
Trending News
More News >
Oryzon Genomics SA (DE:ORN)
FRANKFURT:ORN
Germany Market

Oryzon Genomics SA (ORN) Income Statement

Compare
1 Followers

Oryzon Genomics SA Income Statement

Last quarter (Q4 2024), Oryzon Genomics SA's total revenue was €7.36M, an increase of Infinity% from the same quarter last year. In Q4, Oryzon Genomics SA's net income was €-1.21M. See Oryzon Genomics SA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
€ 7.36M€ 14.19M€ 0.00€ 0.00€ 0.00
Gross Profit
€ 7.06M€ 13.95M€ 15.23M€ 9.87M€ 8.99M
Operating Expenses
€ 11.48M€ 18.50M€ 20.72M€ 16.88M€ 13.28M
Depreciation and Amortization
€ 147.75K€ 152.88K€ 166.66K€ 144.33K€ 145.05K
EBITDA
€ -4.43M€ -4.43M€ -5.35M€ -6.88M€ -4.16M
Operating Income
€ -4.42M€ -4.55M€ -5.49M€ -7.01M€ -4.29M
Other Income/Expenses
€ -1.15M€ -1.55M€ -1.07M€ -169.31K€ -484.51K
Pretax Income
€ -5.57M€ -6.10M€ -6.56M€ -7.18M€ -4.78M
Net Income
€ -3.67M€ -3.35M€ -4.23M€ -4.69M€ -3.40M
Per Share Metrics
Basic EPS
€ -0.06€ -0.06€ -0.08€ -0.09€ -0.06
Diluted EPS
€ -0.06€ -0.06€ -0.08€ -0.09€ -0.06
Weighted Average Shares Outstanding
64.37M 60.88M 56.04M 52.76M 52.76M
Weighted Average Shares Outstanding (Diluted)
64.37M 60.88M 56.04M 52.76M 52.76M
Currency in EUR

Oryzon Genomics SA Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis